Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali, Nikunj Velji Mange, Shraddha Bhanushali & Raj Arvind Bhanushali Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the code of Prohibition of Insider Trading adopted by Company, the trading window for dealing in securities of the company will remain closed from January 01, 2023, till 48 hours after declaration of Financial Results of the Company for the quarter ended December 31, 2022. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Please find attached disclosure in Form - C from Mr. Nikunj Mange, Mr. Jay Bhanushali, Mrs. Shraddha Bhanushali, Mr. Raj Bhanushali pursuant to Regulation 7(2) & 7(3) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Please find attached disclosure in Form - C from Mr. Paresh Bhanushali and Mrs. Geeta Bhanushali pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Please find attached disclosure in Form - C from Mr. Paresh Bhanushali and Mrs. Geeta Bhanushali pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Please find attached disclosure in Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Yashraj Biotechnology Ltd Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures Of Related Party Transactions Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the SEBI Listing Regulations, please find enclosed herewith disclosures of related party transactions in the prescribed format for the half-year ended 30 September 2022. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Please find attached disclosure from Yashraj Biotechnology Limited in Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Directorate
Intimation of Change in Designation of Mr. Arvind Bhanushali (DIN: 00011903) from Executive Director to Non-Executive Director of the Company.